-

Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.

10th Annual SVB Leerink Global Healthcare Conference
Wednesday, Feb. 24 at 7:40 a.m. Pacific time/10:40 a.m. Eastern time
Bob McMahon, Agilent chief financial officer

41st Annual Cowen And Company Healthcare Conference
Thursday, March 4 at 8:10 Pacific time/11:10 a.m. Eastern time
Mike McMullen, Agilent president and CEO

To access these presentations, a Link will be provided in the “News & Events -- Events” portion of the Investor Relations section of the Agilent website.

In addition, the company announced details for the webcast of Agilent’s Annual Shareholder Meeting March 17. To join the meeting, please see the information below.

Agilent Technologies 2021 Annual Meeting of Shareholders
Wednesday, March 17 at 8 a.m. Pacific time/11 a.m. Eastern time
Virtual Meeting log-in beginning at 7:30 a.m. Pacific time
Virtual Meeting access: www.meetingcenter.io/238392758
Password: A2021

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Investor Contact:
Ankur Dhingra
+1 408-345-8948
ankur_dhingra@agilent.com

Media Contact:
Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent announces upcoming investor events and details for annual Shareholder Meeting.
Release Versions
$Cashtags

Contacts

Investor Contact:
Ankur Dhingra
+1 408-345-8948
ankur_dhingra@agilent.com

Media Contact:
Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

More News From Agilent Technologies Inc.

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time...

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the...

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing...
Back to Newsroom